TY  - JOUR

T1  - Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study

JO  - Journal of the American Academy of Dermatology

UR  - https://doi.org/10.1016/j.jaad.2026.07.006

PY  - 2026/07/07

AU  - Irvine AD

AU  - Paller AS

AU  - Siegfried EC

AU  - Cork MJ

AU  - Beck LA

AU  - Eichenfield LF

AU  - Swanson L

AU  - Hamon SC

AU  - Horowitz JE

AU  - Farrell AB

AU  - Hatsell S et al

ED  - 

DO  - DOI: 10.1016/j.jaad.2026.07.006

PB  - Elsevier BV

Y2  - 2026/07/31

ER  -